High Affinity Binders to EphA2 Isolated from Abdurin Scaffold Libraries; Characterization, Binding and Tumor Targeting

• Christopher Ullman,

  Affiliation Isogenica, Ltd. Cambridge, United Kingdom

  ⨯
• Pascale Mathonet,

  Affiliation Isogenica, Ltd. Cambridge, United Kingdom

  ⨯
• Arkadiusz Oleksy,

  Current Address: MRC Technology, London, United Kingdom

  Affiliation Isogenica, Ltd. Cambridge, United Kingdom

  ⨯
• Agata Diamandakis,

  Affiliation Isogenica, Ltd. Cambridge, United Kingdom

  ⨯
• Licia Tomei,

  Affiliation IRBM Science Park, Rome, Italy

  ⨯
• Anna Demartis,

  Affiliation IRBM Science Park, Rome, Italy

  ⨯
• Chiara Nardi,

  Affiliation IRBM Science Park, Rome, Italy

  ⨯
• Sonia Sambucini,

  Affiliation IRBM Science Park, Rome, Italy

  ⨯
• Antonino Missineo,

  Affiliation IRBM Science Park, Rome, Italy

  ⨯
• Karen Alt,

  Affiliation Vascular Biotechnology, Baker IDI, Melbourne, Australia

  ⨯
• Christoph E. Hagemeyer,

  Affiliation Vascular Biotechnology, Baker IDI, Melbourne, Australia

  ⨯
• Matt Harris,

  Affiliation Clarity Pharmaceuticals, Ltd. Sydney, Australia

  ⨯
• Amos Hedt,

  Affiliation Clarity Pharmaceuticals, Ltd. Sydney, Australia

  ⨯
• Roland Weis,

  Affiliation VTU Technology, Grambach, Austria

  ⨯
• Kurt R. Gehlsen

  * E-mail: kgehlsen@rctech.com

  Affiliation Research Corporation Technologies, Inc. Tucson, Arizona, United States of America

  ⨯